Avita Medical Ltd (RCEL) - Total Liabilities

Latest as of December 2025: $73.04 Million USD

Based on the latest financial reports, Avita Medical Ltd (RCEL) has total liabilities worth $73.04 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of Avita Medical Ltd to track the company's year-over-year net asset growth rate.

Avita Medical Ltd - Total Liabilities Trend (1993–2025)

This chart illustrates how Avita Medical Ltd's total liabilities have evolved over time, based on quarterly financial data. See RCEL free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Avita Medical Ltd Competitors by Total Liabilities

The table below lists competitors of Avita Medical Ltd ranked by their total liabilities.

Company Country Total Liabilities
Champion Microelectronic Corp
TW:3257
Taiwan NT$1.06 Billion
Oxford Square Capital Corp
NASDAQ:OXSQ
USA $155.78 Million
Singular People S.A.
MC:SNG
Spain €43.61 Million
Bhiraj Office Leasehold Real Estate Investment Trust
BK:BOFFICE
Thailand ฿2.56 Billion
DongWon Development Co.Ltd
KQ:013120
Korea ₩361.51 Billion
NET Power Inc.
NYSE:NPWR
USA $24.95 Million
PKP Cargo S.A.
WAR:PKP
Poland zł5.48 Billion
Corpovael S.A.B. de C.V
MX:CADUA
Mexico MX$6.43 Billion

Liability Composition Analysis (1993–2025)

This chart breaks down Avita Medical Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Avita Medical Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.57 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -4.39 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 1.30 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Avita Medical Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Avita Medical Ltd (1993–2025)

The table below shows the annual total liabilities of Avita Medical Ltd from 1993 to 2025.

Year Total Liabilities Change
2025-12-31 $73.04 Million -2.89%
2024-12-31 $75.21 Million +20.18%
2023-12-31 $62.58 Million +362.76%
2022-12-31 $13.52 Million +18.73%
2021-12-31 $11.39 Million +13.22%
2020-12-31 $10.06 Million +103.17%
2019-12-31 $4.95 Million +23.34%
2017-12-31 $4.01 Million +57.68%
2016-12-31 $2.55 Million +45.46%
2015-12-31 $1.75 Million +42.74%
2014-12-31 $1.23 Million -31.35%
2013-12-31 $1.79 Million -27.19%
2012-12-31 $2.45 Million +14.00%
2011-12-31 $2.15 Million +26.54%
2010-12-31 $1.70 Million -56.17%
2009-12-31 $3.88 Million +287.84%
2008-12-31 $1.00 Million -60.72%
2007-12-31 $2.55 Million +138.67%
2006-12-31 $1.07 Million -44.69%
2005-12-31 $1.93 Million +38.67%
2004-12-31 $1.39 Million +172.15%
2003-12-31 $511.27K +63.12%
2002-12-31 $313.44K -40.36%
2001-12-31 $525.57K +1351.65%
2000-12-31 $36.21K -58.71%
1999-12-31 $87.69K +342.35%
1998-12-31 $19.82K +4.35%
1997-12-31 $19.00K -61.80%
1996-12-31 $49.74K -41.90%
1995-12-31 $85.60K -64.52%
1994-12-31 $241.24K -36.85%
1993-12-31 $381.99K --

About Avita Medical Ltd

NASDAQ:RCEL USA Medical Devices
Market Cap
$135.42 Million
Market Cap Rank
#18242 Global
#4226 in USA
Share Price
$4.40
Change (1 day)
-2.00%
52-Week Range
$3.27 - $6.76
All Time High
$55.20
About

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitili… Read more